APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 143 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,464,000 | -25.6% | 80,727 | -0.8% | 2.81% | -20.9% |
Q4 2020 | $4,654,000 | +100.9% | 81,357 | +5.9% | 3.55% | +93.9% |
Q3 2020 | $2,317,000 | -4.7% | 76,804 | +3.2% | 1.83% | +7.5% |
Q2 2020 | $2,432,000 | +19.3% | 74,452 | 0.0% | 1.70% | -15.2% |
Q1 2020 | $2,038,000 | -11.5% | 74,452 | -1.0% | 2.01% | +30.0% |
Q4 2019 | $2,303,000 | – | 75,227 | – | 1.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |